(R)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)-3-phenethylbenzamide

ID: ALA1078749

PubChem CID: 46882031

Max Phase: Preclinical

Molecular Formula: C30H31N3O2

Molecular Weight: 465.60

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCc2ccccc2)c1

Standard InChI:  InChI=1S/C30H31N3O2/c34-29(27-10-5-18-31-21-27)22-32-19-17-24-13-15-28(16-14-24)33-30(35)26-9-4-8-25(20-26)12-11-23-6-2-1-3-7-23/h1-10,13-16,18,20-21,29,32,34H,11-12,17,19,22H2,(H,33,35)/t29-/m0/s1

Standard InChI Key:  BRXXHSMZWQFXJQ-LJAQVGFWSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    9.7236   -8.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7224   -8.9357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4372   -9.3485    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1537   -8.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1508   -8.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4354   -7.6955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8637   -7.6895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5797   -8.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8606   -6.8645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2927   -7.6841    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0087   -8.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7216   -7.6787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4376   -8.0885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4378   -8.9136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1530   -9.3233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8669   -8.9081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8611   -8.0788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1454   -7.6728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5835   -9.3169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2958   -8.9008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2916   -8.0758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0124   -9.3096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0139  -10.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7296  -10.5432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4430  -10.1270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4361   -9.2978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7198   -8.8927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7334  -11.3682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0209  -11.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0247  -12.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3105  -13.0228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3140  -13.8471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0309  -14.2571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7458  -13.8369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7388  -13.0140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17 18  2  0
 18 13  1  0
  7  9  1  1
 16 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
  2  3  1  0
 20 22  1  0
 10 11  1  0
 22 23  2  0
  5  6  2  0
 23 24  1  0
 11 12  1  0
 24 25  2  0
  6  1  1  0
 25 26  1  0
 12 13  1  0
 26 27  2  0
 27 22  1  0
  1  2  2  0
 24 28  1  0
 13 14  2  0
 28 29  1  0
  5  7  1  0
 29 30  1  0
 14 15  1  0
 30 31  2  0
  3  4  2  0
 31 32  1  0
 15 16  2  0
 32 33  2  0
  7  8  1  0
 33 34  1  0
 16 17  1  0
 34 35  2  0
 35 30  1  0
M  END

Associated Targets(Human)

ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.60Molecular Weight (Monoisotopic): 465.2416AlogP: 4.98#Rotatable Bonds: 11
Polar Surface Area: 74.25Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.87CX Basic pKa: 9.45CX LogP: 5.32CX LogD: 3.29
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.27Np Likeness Score: -0.88

References

1. Goble SD, Wang L, Howell KL, Bansal A, Berger R, Brockunier L, DiSalvo J, Feighner S, Harper B, He J, Hurley A, Hreniuk D, Parmee E, Robbins M, Salituro G, Sanfiz A, Streckfuss E, Watkins E, Weber AE, Struthers M, Edmondson SD..  (2010)  Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles.,  20  (6): [PMID:20181479] [10.1016/j.bmcl.2010.01.130]

Source